FDA approves new drug to treat adults with relapsing forms of MS

The U.S. Food and Drug Administration today approved Mayzent (siponimod) tablets to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

Source link

Related posts

beautifulmedicine: Xray: shows bone/skull only. Does not show…


Assessing measurement invariance of MSQOL-54 across Italian and English versions.


Paraneoplastic neuronal intermediate filament autoimmunity


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy